These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38543500)

  • 21. Omicron (BA.1) and sub-variants (BA.1.1, BA.2, and BA.3) of SARS-CoV-2 spike infectivity and pathogenicity: A comparative sequence and structural-based computational assessment.
    Kumar S; Karuppanan K; Subramaniam G
    J Med Virol; 2022 Oct; 94(10):4780-4791. PubMed ID: 35680610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative complete scheme and booster effectiveness of COVID-19 vaccines in preventing SARS-CoV-2 infections with SARS-CoV-2 Omicron (BA.1) and Delta (B.1.617.2) variants: A case-case study based on electronic health records.
    Kislaya I; Peralta-Santos A; Borges V; Vieira L; Sousa C; Ferreira B; Pelerito A; Gomes JP; Leite PP; Nunes B; ; Machado A; Rodrigues AP; Peixoto VR; Casaca P; Fernandes E; Rodrigues E; Ferreira R; Isidro J; Pinto M; Duarte S; Santos D; Meneses L; Almeida JP; Matias A; Freire S; Grilo T
    Influenza Other Respir Viruses; 2023 Mar; 17(3):e13121. PubMed ID: 36935845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spatiotemporal genome diversity of SARS-CoV-2 in wastewater: a two-year global epidemiological study.
    Mandal M; Mandal S
    Environ Monit Assess; 2023 Dec; 196(1):44. PubMed ID: 38102322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of SARS-Cov-2 omicron variant with the previously identified SARS-Cov-2 variants in Egypt, 2020-2022: insight into SARS-Cov-2 genome evolution and its impact on epidemiology, clinical picture, disease severity, and mortality.
    Kandeel A; Moatasim Y; Fahim M; Bahaaeldin H; El-Shesheny R; Roshdy WH; Kamel MN; Shawky S; Gomaa M; Naguib A; Guindy NE; Deghedy O; Kamel R; Khalifa M; Galal R; Hassany M; Mahmoud G; Kandeil A; Afifi S; Mohsen A; Fattah MA; Kayali G; Ali MA; Abdelghaffar K
    BMC Infect Dis; 2023 Aug; 23(1):542. PubMed ID: 37596534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Re-emergence of Gamma-like-II and emergence of Gamma-S:E661D SARS-CoV-2 lineages in the south of Brazil after the 2021 outbreak.
    Oliveira MM; Schemberger MO; Suzukawa AA; Riediger IN; do Carmo Debur M; Becker G; Resende PC; Gräf T; Balsanelli E; de Baura VA; de Souza EM; Pedrosa FO; Alves LR; Blanes L; Nardelli SC; Aguiar AM; Albrecht L; Zanette D; Ávila AR; Morello LG; Marchini FK; Dos Santos HG; Passetti F; Dallagiovanna B; Faoro H
    Virol J; 2021 Nov; 18(1):222. PubMed ID: 34789293
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulation of SARS-CoV-2 Omicron sub-lineages revealed by multiplex genotyping RT-qPCR assays for sewage surveillance.
    Ding J; Xu X; Deng Y; Zheng X; Zhang T
    Sci Total Environ; 2023 Dec; 904():166300. PubMed ID: 37591390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low SARS-CoV-2 viral load among vaccinated individuals infected with Delta B.1.617.2 and Omicron BA.1.1.529 but not with Omicron BA.1.1 and BA.2 variants.
    Selvavinayagam ST; Yong YK; Joseph N; Hemashree K; Tan HY; Zhang Y; Rajeshkumar M; Kumaresan A; Kalpana R; Kalaivani V; Monika AVD; Suvaithenamudhan S; Kannan M; Murugesan A; Narayanasamy K; Palani S; Larsson M; Shankar EM; Raju S
    Front Public Health; 2022; 10():1018399. PubMed ID: 36211690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Wastewater surveillance of SARS-CoV-2 variants in October-November 2022 in Italy: detection of XBB.1, BA.2.75 and rapid spread of the BQ.1 lineage.
    La Rosa G; Brandtner D; Bonanno Ferraro G; Veneri C; Mancini P; Iaconelli M; Lucentini L; Del Giudice C; Orlandi L; ; Suffredini E
    Sci Total Environ; 2023 May; 873():162339. PubMed ID: 36813191
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination history.
    Townsley H; Gahir J; Russell TW; Greenwood D; Carr EJ; Dyke M; Adams L; Miah M; Clayton B; Smith C; Miranda M; Mears HV; Bailey C; Black JRM; Fowler AS; Crawford M; Wilkinson K; Hutchinson M; Harvey R; O'Reilly N; Kelly G; Goldstone R; Beale R; Papineni P; Corrah T; Gilson R; Caidan S; Nicod J; Gamblin S; Kassiotis G; Libri V; Williams B; Gandhi S; Kucharski AJ; Swanton C; Bauer DLV; Wall EC
    PLoS One; 2024; 19(3):e0294897. PubMed ID: 38512960
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New Surveillance Metrics for Alerting Community-Acquired Outbreaks of Emerging SARS-CoV-2 Variants Using Imported Case Data: Bayesian Markov Chain Monte Carlo Approach.
    Yen AM; Chen TH; Chang WJ; Lin TY; Jen GH; Hsu CY; Wang ST; Dang H; Chen SL
    JMIR Public Health Surveill; 2022 Nov; 8(11):e40866. PubMed ID: 36265134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular epidemiology of the SARS-CoV-2 variant Omicron BA.2 sub-lineage in Denmark, 29 November 2021 to 2 January 2022.
    Fonager J; Bennedbæk M; Bager P; Wohlfahrt J; Ellegaard KM; Ingham AC; Edslev SM; Stegger M; Sieber RN; Lassauniere R; Fomsgaard A; Lillebaek T; Svarrer CW; Møller FT; Møller CH; Legarth R; Sydenham TV; Steinke K; Paulsen SJ; Castruita JAS; Schneider UV; Schouw CH; Nielsen XC; Overvad M; Nielsen RT; Marvig RL; Pedersen MS; Nielsen L; Nilsson LL; Bybjerg-Grauholm J; Tarpgaard IH; Ebsen TS; Lam JUH; Gunalan V; Rasmussen M
    Euro Surveill; 2022 Mar; 27(10):. PubMed ID: 35272746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid emergence of SARS-CoV-2 Omicron variant is associated with an infection advantage over Delta in vaccinated persons.
    Chaguza C; Coppi A; Earnest R; Ferguson D; Kerantzas N; Warner F; Young HP; Breban MI; Billig K; Koch RT; Pham K; Kalinich CC; Ott IM; Fauver JR; Hahn AM; Tikhonova IR; Castaldi C; De Kumar B; Pettker CM; Warren JL; Weinberger DM; Landry ML; Peaper DR; Schulz W; Vogels CBF; Grubaugh ND
    Med; 2022 May; 3(5):325-334.e4. PubMed ID: 35399324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutational characterization of Omicron SARS-CoV-2 lineages circulating in Chhattisgarh, a central state of India.
    Singh P; Sharma K; Shaw D; Bhargava A; Negi SS
    Front Med (Lausanne); 2022; 9():1082846. PubMed ID: 36755883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics of the First 284 Patients Infected with the SARS-CoV-2 Omicron BA.2 Subvariant at a Single Center in the Apulia Region of Italy, January-March 2022.
    Loconsole D; Centrone F; Sallustio A; Accogli M; Casulli D; Sacco D; Zagaria R; Morcavallo C; Chironna M
    Vaccines (Basel); 2022 Apr; 10(5):. PubMed ID: 35632430
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Omicron variant BA.1.1 presents a lower pathogenicity than B.1 D614G and Delta variants in a feline model of SARS-CoV-2 infection.
    Martins M; do Nascimento GM; Nooruzzaman M; Yuan F; Chen C; Caserta LC; Miller AD; Whittaker GR; Fang Y; Diel DG
    bioRxiv; 2022 Jun; ():. PubMed ID: 35734088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prolonged replication of BA.1 and BA.2 Omicron lineages compared to Delta variant in nasopharyngeal samples from COVID-19 patients.
    Teyssou E; Marot S; Cocherie T; Fauchois A; Abdi B; Todesco E; Akhavan S; Pourcher V; Calvez V; Marcelin AG; Soulie C
    Infect Dis Now; 2023 Feb; 53(1):104629. PubMed ID: 36323397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bayesian Molecular Dating Analyses Combined with Mutational Profiling Suggest an Independent Origin and Evolution of SARS-CoV-2 Omicron BA.1 and BA.2 Sub-Lineages.
    Kumar N; Kaushik R; Singh A; Uversky VN; Zhang KYJ; Sahu U; Bhatia S; Sanyal A
    Viruses; 2022 Dec; 14(12):. PubMed ID: 36560768
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SARS-CoV-2 Omicron Variant in Croatia-Rapid Detection of the First Case and Cross-Border Spread.
    Ferenčak I; Obrovac M; Žmak L; Kuzle J; Petrović G; Vilibić-Čavlek T; Jurić D; Jurić A; Hruškar Ž; Capak K; Stevanović V; Milanović M; Govedarica M; Vujošević D; Tabain I
    Pathogens; 2022 Apr; 11(5):. PubMed ID: 35631032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Omicron Variant BA.1.1 Presents a Lower Pathogenicity than B.1 D614G and Delta Variants in a Feline Model of SARS-CoV-2 Infection.
    Martins M; do Nascimento GM; Nooruzzaman M; Yuan F; Chen C; Caserta LC; Miller AD; Whittaker GR; Fang Y; Diel DG
    J Virol; 2022 Sep; 96(17):e0096122. PubMed ID: 36000850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Uninvited Guest: Arrival and Dissemination of Omicron Lineage SARS-CoV-2 in St. Petersburg, Russia.
    Gladkikh A; Dedkov V; Sharova A; Klyuchnikova E; Sbarzaglia V; Arbuzova T; Forghani M; Ramsay E; Dolgova A; Shabalina A; Tsyganova N; Totolian A
    Microorganisms; 2022 Aug; 10(8):. PubMed ID: 36014093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.